Globus Medical (GMED) Financial Statements
Globus Medical Financial Overview
Globus Medical's market cap is currently $196.86B. The company's EPS TTM is $3.97; its P/E ratio is 19.66; Globus Medical is scheduled to report earnings on November 5, 2026, and the estimated EPS forecast is $22.49. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.94B | $ 2.52B | $ 1.57B | $ 1.02B | $ 958.10M |
| Gross Profit | $ 1.98B | $ 1.48B | $ 1.02B | $ 759.12M | $ 718.88M |
| Operating Income | $ 479.80M | $ 165.99M | $ 133.14M | $ 227.95M | $ 171.95M |
| EBITDA | $ 886.74M | $ 473.73M | $ 346.58M | $ 304.50M | $ 264.73M |
| Net Income | $ 537.90M | $ 102.98M | $ 122.87M | $ 190.17M | $ 149.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 557.24M | $ 890.06M | $ 517.79M | $ 446.06M | $ 443.45M |
| Total Assets | $ 5.30B | $ 5.25B | $ 5.09B | $ 2.08B | $ 1.96B |
| Total Debt | $ 118.66M | $ 537.19M | $ 520.40M | $ 6.01M | $ 0.00 |
| Net Debt | $ -407.50M | $ -247.25M | $ 53.11M | $ -144.46M | $ -193.07M |
| Total Liabilities | $ 729.51M | $ 1.07B | $ 1.09B | $ 229.75M | $ 215.88M |
| Stockholders' Equity | $ 4.57B | $ 4.18B | $ 4.00B | $ 1.85B | $ 1.74B |
| Cash Flow | |||||
| Free Cash Flow | $ 588.77M | $ 405.21M | $ 165.22M | $ 104.42M | $ 219.38M |
| Operating Cash Flow | $ 753.45M | $ 520.64M | $ 243.50M | $ 178.47M | $ 276.27M |
| Investing Cash Flow | $ -355.01M | $ -176.05M | $ 302.97M | $ -110.36M | $ -375.94M |
| Financing Cash Flow | $ -679.16M | $ -27.70M | $ -231.82M | $ -109.96M | $ 54.15M |
Currency in USD